Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
08/2012
08/23/2012US20120214991 Indenone Derivative and Pharmaceutical Composition Comprising Same
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214808 Aryl Urea Derivatives for Treating Obesity
08/23/2012US20120214794 Heteroaryls and uses thereof
08/23/2012US20120214785 New compounds, pharmaceutical compositions and uses thereof
08/23/2012US20120214769 Novel Antagonists of the Glucagon Receptor
08/22/2012EP2489658A1 3-Heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
08/22/2012EP2489350A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
08/22/2012EP2488483A1 A process for the preparation of 2-(2-aminoethoxy) ethanol (2aee) and morpholine with 2aee: morpholine>3
08/22/2012EP1841731B1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
08/22/2012EP1727782B1 Method of producing aminophenol compounds
08/22/2012CN102643252A Piperazinoacethydrazide-containing diarylurea derivatives and application thereof
08/22/2012CN102643251A Linezolid degradation impurity and preparation method thereof
08/22/2012CN102643250A Recovery method of piperazine in condensation mother liquor for preparing ciprofloxacin
08/22/2012CN102643207A 3-(2-naphthyl) acrylamide derivatives as well as preparation method and application thereof
08/22/2012CN102643178A Preparation methods of lasofoxifene tartrate and intermediate thereof
08/22/2012CN101973964B Method for separating and extracting 2,2-dimorpholinyl diethyl ether from high-boiling morpholine residues
08/22/2012CN101842093B PAI-1 production inhibitor
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247452 Urea- and urethane-substituted acylureas, process for their preparation and their use
08/21/2012US8247404 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
08/21/2012US8246793 Method for the continuous separation of mixtures comprising morpholine (MO), monoaminodiglycol (ADG), ammonia and water by means of distillation
08/21/2012CA2479877C Substituted tetracycline compounds
08/16/2012WO2004053071A9 Method for discovering neurogenic agents
08/16/2012US20120204763 Phenolic compound and recording material
08/15/2012CN102633992A Low-viscosity anacardol modified amine curing agent as well as preparation method and application thereof
08/15/2012CN102633927A Ionic liquid modified carbine, preparation method for same and application thereof
08/15/2012CN102633750A One-pot method for synthesizing repaglinide for treating diabetes
08/15/2012CN102633749A Preparation method of 1-(4-(2-methoxy ethyoxyl) phenyl) piperazine hydrochloride
08/15/2012CN101570496B Curcumin-4-nitrogen-containing derivatives, and preparation method and uses thereof
08/14/2012US8242286 Phenoxy-pyrrolidine derivative and its use and compositions
08/14/2012US8242175 Class of histone deacetylase inhibitors
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/14/2012CA2684571C Novel therapeutic uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine
08/14/2012CA2468302C Compounds for treatment of inflammation, diabetes and related disorders
08/09/2012WO2012104788A2 Anti-angiogenic compounds, pharmaceutical compositions containing same, and use thereof
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012US20120202994 Method for Carrying Out Chemical Reactions with the Aid of an Inductively Heated Heating Medium
08/08/2012EP2484661A1 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same
08/08/2012CN102627518A Preparation method of N-nitrosamine
08/07/2012CA2600973C .delta.-amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid
08/02/2012WO2012101946A1 Novel compound, dye and colored photosensitive composition
08/02/2012WO2012101648A1 Novel process for the synthesis of enantiomerically pure 2-methoxy-5-[(2r)-2-(4-alkylpiperazin-l-yl)propyl]-benzenesulfonamide
08/02/2012WO2012101475A1 An improved process for the preparation of antihistaminic drugs via a novel carbamate intermediate
08/02/2012WO2012101453A1 Protease activated receptor 2 (par2) antagonists
08/02/2012WO2012063085A3 Drug derivatives
08/02/2012US20120197015 EPOXYCARBOXAMIDE COMPOUND, AZIDE COMPOUND, AND AMINO ALCOHOL COMPOUND, AND PROCESS FOR PREPARING a-KETO AMIDE COMPOUND USING THEM
08/02/2012US20120197009 Isolation of nucleic acids
08/02/2012US20120196944 Isolation of nucleic acids
08/02/2012US20120196895 Novel forms of eperisone
08/02/2012US20120196874 Stilbene analogs and methods of treating cancer
08/02/2012US20120196865 Acyl Guanidine Derivatives Modulating The Hedgehog Protein Signaling Pathway
08/02/2012US20120196852 Inhibitors of methionine aminopeptidases and methods of treating disorders
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120196378 Methods, Mixtures, Kits and Compositions Pertaining to Analyte Determination
08/02/2012CA2824536A1 Protease activated receptor 2 (par2) antagonists
08/01/2012EP2481723A2 Substituted tetracycline compounds
08/01/2012EP2032535B1 Spirocyclic nitriles as protease inhibitors
08/01/2012EP1799663B1 Modulators of HCV replication
08/01/2012EP1753421B1 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
08/01/2012EP1560810B1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
08/01/2012CN102617690A Vitamin d derivatives
08/01/2012CN102617513A 1- [2- (2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 AND 5-HT1A activity for the treatment of cognitive impairment
08/01/2012CN102617512A Method for preparation of tetrahydropyrrole
08/01/2012CN102617391A Resveratrol benzene acrylamide derivative, preparing method and application thereof
08/01/2012CN102617342A (+/-)-alkannin naphthazarin parent nucleus oxygen alkyl acylation derivant and preparation method thereof
08/01/2012CN102617339A 3-cyclopropylmethoxy-4-halogen benzoic acid or derivative and application thereof
07/2012
07/31/2012US8232421 Bifunctional phenyl ISO (THIO) cyanates, processes and intermediates for their preparation
07/31/2012CA2655212C 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
07/31/2012CA2550080C Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines
07/26/2012US20120190846 Michael addition reaction product and active energy ray-curable composition
07/26/2012US20120190820 Facile amide formation via s-nitroso thioacid intermediates
07/26/2012US20120189697 Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
07/25/2012EP2479613A1 Photopolymerizable composition, color filter, method for producing same, solid-state image pickup element, liquid crystal display device, lithographic printing original plate, and novel compound
07/25/2012EP2477972A1 Abt-263 crystalline forms and solvates for use in treating bcl-2 protein related diseases
07/25/2012EP2477969A1 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases
07/25/2012EP2477968A1 N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl]benzamide compounds, their preparation and their use as tace inhibitors
07/25/2012CN102604088A Macromolecule mercaptan and synthetic method thereof
07/25/2012CN102603679A Phenylpropyl piperazine derivative and analgesic usage thereof
07/25/2012CN102603678A Diphenyl-methyl piperazine compound, preparation and use of the diphenyl-methyl piperazine compound
07/25/2012CN102603677A Curcumin-4-mannich base derivative, preparation method and use of curcumin-4-mannich base derivative
07/25/2012CN102603676A Phosphodiesterase 4 inhibitor capable of avoiding vomiting reaction
07/25/2012CN102603675A Piperazine compound and application thereof
07/25/2012CN102603674A Gas hydrate generation promoter and preparation method thereof
07/25/2012CN102603581A Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors
07/25/2012CN102603555A All-trans retinoic acid amide derivative and preparation method and application thereof
07/25/2012CN102603552A Preparation method of alpha-keto amide
07/25/2012CN102600884A Preparation method for ethanediamine synthesis piperazine catalyst
07/25/2012CN102600844A Ni-NiO/gamma-Al2O3 catalyst for preparing pyridine and pyridine byproducts as well as preparation method
07/25/2012CN101850270B Application of central palladium phosphine ferrocenylimine complex for catalyzing and synthesizing amine-methylated aromatic compound
07/25/2012CN101602751B Preparation method of cinepazide maleate
07/24/2012US8227607 Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof
07/24/2012US8227604 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity
07/24/2012US8226966 Fungicide N-6-membered fused (hetero) aryl-methylene-N-cycloalkyl carboxamide derivatives
07/24/2012CA2690226C Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
07/24/2012CA2476065C Inhibitors of histone deacetylase
07/19/2012US20120184737 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
07/19/2012US20120184735 2,3-dihydro-1h-indene-2-yl urea derivative and pharmaceutical application of same
07/19/2012US20120184520 Glycine compound
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 341